Comparison of A Histopathologic Grading Between the Xenografte Mouse Model of Lung Cancer Adenocarcinoma, and Colloid Gold with Camostat Mesilate Powder Intaking Group by Hematoxylin and Eosine Stain

Short Report

Comparison of A Histopathologic Grading Between the Xenografte Mouse Model of Lung Cancer Adenocarcinoma, and Colloid Gold with Camostat Mesilate Powder Intaking Group by Hematoxylin and Eosine Stain

Chur Chin ^*

Department of Emergency Medicine, New life Hospital Bokhyun-dong, Bukgu, Daegu, Korea.

*Corresponding Author: Chur Chin, Department of Emergency Medicine, New life Hospital Bokhyun-dong, Bukgu, Daegu, Korea.

Citation: Chin C. (2024). Comparison of A Histopathologic Grading Between the Xenografte Mouse Model of Lung Cancer Adenocarcinoma, and Colloid Gold with Camostat Mesilate Powder Intaking Group by Hematoxylin and Eosine Stain. Clinical Case Reports and Studies, BioRes Scientia Publishers. 5(3):1-3. DOI: 10.59657/2837-2565.brs.24.117

Copyright: © 2024 Chur Chin, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: March 02, 2024 | Accepted: March 15, 2024 | Published: March 18, 2024

Abstract

Keywords: histopathologic grading; lung cancer; eosine stain

Description

Previously, we developed nontoxic, broad-spectrum virucidal gold nanoparticles, less than 10nm sized, modified with sulfonic acids with camostat, a serine protease inhibitor can introduce gold nanoparticles to the influenza virus via ionic bonds [1]. Moreover, this nontoxic drug irreversibly removes gene fragments inhibit insertion into the host genome [2]. Lewis’s lung cancer cell line derived xenografts are generated by transplanting into immune-deficient mice. We have identified the response of the lung adenocarcinoma to colloid gold with camostat mesilate powder intaking. Comparative analysis of the histology by formalin-fixation and paraffin-embedding were done from 4 control mice and 5 intaking mice. All tumors were collected and engrafted within 2h post resection. Each case was reviewed by pathologists to confirm the diagnosis. Mice were sacrificed by intraperitoneal injection of ketamine/xylazine (90/8mg/kg). 3 weeks after implantation.

Lewis lung carcinoma is a hypermutated Kras/Nras–mutant cancer with extensive regional mutation clusters in its genome. A tumor that spontaneously developed as an epidermoid carcinoma in the lung of a C57BL mouse. Syngeneic models have proven to be useful in predicting clinical benefit of therapy in preclinical experiments. The cells were anaplastic, varying in size and shape; and they appeared to have little cytoplasm. The nuclei of the cells were highly distorted and prominent.

Figure 1(A): Control: high-grade components: micropapillary and solid patterns by the International Association for the Study of Lung Cancer.

Figure 1(B): Intake group: lepidic and papillary patterns

Figure 1: Histologic analysis of colloid gold with camostat mesilate powder intaking group and Xenograft mouse model: (A) control group: cribriform pattern characterized by nests of neoplastic cells with perforated sieve; (B) intake group: lepidic patterns.

Table 1: Comparative analysis of the histology by hematoxylin-eosine stain: (A) Control group: grade 3; (B) Intake group: grade 1

Predominant histologic pattern, n (%)	Control	Intake group
Lepidic		5
acinar		2
papillary	1
Solid	4
Complex glands (cribriform and fused glands)	3

References

Chin C. (2021). Cell entry inhibitor with sulfonated colloid gold as new potent broad spectrum virucides. J Infect Dis Ther., 9:1-4.
Publisher | Google Scholor
Chin C. (2024). Collloidal Gold with Camostat Mesylate Powder Remove DNA and RNA from Living Object, International journal of clinical case report and review. 16(2):1-5.
Publisher | Google Scholor
Andrea L Moreira, Paolo S Ocampo, Yuhe Xia, Hua Zhong, Prudence A Russell, et al. (2020). A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol., 15(10):1599-1610.
Publisher | Google Scholor

Delia Teresa Sponza

"Journal of BioMed Research and Reports has created a diverse portfolio in peer review process and provides a wide range scientific and medical novel papers to the scientists. This journal publishes high-quality, peer-reviewed content across all levels of professional development and corporate research and development."

Fatema Tashrifwala

I would like to thank the editorial team for their timely responses and consideration in the publication of my paper. They have been very helpful and accommodating, Lastly, being an open access journal, the published work is freely available and accessible to readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nikhil Vitthal Dayama

I would like to thank the editorial team for their timely and prompt responses and consideration in the publication of my case report. Being an open access journal, it will be great help for the readers to learn the new things without any cost. I would encourage the authors to publish their research in BioRes Scientia and I am happy to be part of this journal.

Boubacar Ahy Diatta

I warmly thank the editorial team for the excellent work they do for continuing medical education in Dermatology. I was able to discover with joy their professionalist, their support and above all appreciate their social generosity on the access to the magazines which is free. This allows an update of scientific knowledge to the entire scientific community. I gladly recommend authors for publication in this journal.

Professor Rajko Igic

The editor of JBRR helped me during the whole process, mainly to eliminate some typographical and other errors. It hastened this publication to be published quickly. Although it is a short text, I believe that the content is important for all medical and other scientific disciplines because eventual addition of the iC citations to citation of the paper would lead to proper assessment of the author's contribution.

Dr Tewodros kassahun Tarekegn

I am thrilled to have had the opportunity to publish my research article in this prestigious journal. The entire process of peer review and publication support provided by the editorial office was exceptional, and it fortified my belief in the quality of my research study. The rigorous peer review process ensured that only the highest quality research was published, and the feedback from the reviewers was extremely helpful. I appreciate the journal's commitment to open access publication, enabling my research to reach a wider audience. The easy-to-use online platform streamlined the submission, peer review, and publication process, and I would confidently recommend this journal to any author looking for efficient, rigorous, and high-quality peer-reviewed publication.

Francis Okello Ooko

I was impressed by your author-centred approach whereby you maintained constant and timely communication with us from the time we submitted the manuscript to acceptance, each time providing critical suggestions to improve the manuscript. In addition, we are encouraged by the thoroughness of your editorial team in checking the originality and overall, quality of the work. Which I believe is very encouraging to other researchers and authors who wish to publish their work in your journals. The published work and the information imparted is freely available and accessible to a wide spectrum of readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nidhi Sapolia

I would like to thank the editorial team of their timely response and guidance in the publication of my case report. They have been extremely helpful at all stages. Being an open access journal, it is of great help for the readers to learn new experiences in different fields, I would highly recommend this journal to authors for high quality peer-reviewed publications.

Dwight L Mckee MD CNS ABIHM

I am very impressed by the high quality of the papers published by the International Journal of Clinical and Molecular Oncology. The editors of this journal are a pleasure to work with, as they are highly responsive even to numerous last minute changes in the manuscript that I recently published with them, and the changes are made on-line the same day they are received. I highly recommend this journal to anyone working in the oncology field, and also value it as a source of cutting edge information in the field.

Kyaw Swar Thet

I would like to thank the editorial team for the opportunity to publish our case report in this prestigious journal. I am very impressed by their timely and efficient handling of the submission, peer review, and publication processes. As residents of a developing, low-income country, we greatly appreciate the discount on submission charges. I hope that as an open access journal, it will facilitate easy access for readers to update their scientific knowledge. I highly recommend this journal for high-quality, peer-reviewed publications. I express my sincere gratitude to the editorial team for their excellent work.

Michel Farah

I would like to thank the editorial team for their quick response and support. The publication support and editorial office were excellent and very helpful. I am happy to have my research article published in this prestigious journal. Our previous case report published in this journal was very successful and viewed by many physicians worldwide.